FIELD: chemistry.
SUBSTANCE: invention relates to a compound having a chemical structure: PTM-L-CLM, where L is covalently bonded to said PTM and said CLM and is presented in the form of formula -(A')q-, PTM is a low-molecular-weight protein-focused fragment, which specifically binds to an intracellular target protein or intracellular target polypeptide for performing ubiquitination of intracellular target protein or intracellular target polypeptide when coupled with CLM; CLM is a fragment which binds the ubiquitin-ligase E3, which has a chemical structure represented by the formula:
.
Values of other radicals are given in the patent claim. Invention also relates to pharmaceutical compositions, methods for inducing destruction of intracellular protein target or intracellular polypeptide target, compounds.
EFFECT: obtaining novel bifunctional compounds providing recruitment of proteins to ubiquitin-ligase E3 for their destruction.
24 cl, 1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDES BASED PROTEOLYSIS MODULATORS AND RELATED METHODS OF USE | 2016 |
|
RU2704807C2 |
| CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
| ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER | 2009 |
|
RU2527952C2 |
| COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
| METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MAINTENANCE OF CANCER AND OTHER DISEASES | 2004 |
|
RU2348407C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| 5-SUBSTITUTED ISOINDOLINE COMPOUNDS | 2007 |
|
RU2448101C2 |
| ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
| TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DESTROYERS | 2017 |
|
RU2797244C2 |
| CONDENSED HETEROCYCLIC SUCCINAMIDE COMPOUNDS | 2001 |
|
RU2298554C2 |
